5-(4-[(3-Methylbut-2-en-1-yl)oxy]phenyl)-2-(5-(pyrrolidin-1-ylmethyl)pyridin-2-yl)oxazole

ID: ALA4092956

PubChem CID: 137653728

Max Phase: Preclinical

Molecular Formula: C24H27N3O2

Molecular Weight: 389.50

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)=CCOc1ccc(-c2cnc(-c3ccc(CN4CCCC4)cn3)o2)cc1

Standard InChI:  InChI=1S/C24H27N3O2/c1-18(2)11-14-28-21-8-6-20(7-9-21)23-16-26-24(29-23)22-10-5-19(15-25-22)17-27-12-3-4-13-27/h5-11,15-16H,3-4,12-14,17H2,1-2H3

Standard InChI Key:  WYNSDAPBIAEVER-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    5.8424   -6.1084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.3902   -5.4978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9816   -4.7929    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1832   -4.9636    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0951   -5.7740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2006   -5.5860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5350   -6.3333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3454   -6.4173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8256   -5.7582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4953   -5.0109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6808   -4.9269    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6401   -5.8422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1202   -5.1831    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.9374   -5.1831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1880   -4.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5288   -3.9216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8656   -4.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3860   -6.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810   -5.7740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9719   -6.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9719   -6.9998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6810   -7.4084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3860   -6.9998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2628   -7.4084    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.5579   -6.9998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5579   -6.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8488   -5.7740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8488   -4.9569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1438   -6.1826    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  1  5  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  6 11  2  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 13 17  1  0
 12 13  1  0
  9 12  1  0
  2  6  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 18 23  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 27 29  1  0
 24 25  1  0
 21 24  1  0
  5 18  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4092956

    ---

Associated Targets(Human)

MDA-MB-453 (1139 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC1937 (423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCC70 (557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-549 (31254 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 389.50Molecular Weight (Monoisotopic): 389.2103AlogP: 5.34#Rotatable Bonds: 7
Polar Surface Area: 51.39Molecular Species: BASEHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 8.58CX LogP: 4.23CX LogD: 3.02
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -0.64

References

1. Robles AJ, McCowen S, Cai S, Glassman M, Ruiz F, Cichewicz RH, McHardy SF, Mooberry SL..  (2017)  Structure-Activity Relationships of New Natural Product-Based Diaryloxazoles with Selective Activity against Androgen Receptor-Positive Breast Cancer Cells.,  60  (22): [PMID:29053266] [10.1021/acs.jmedchem.7b01228]

Source